Patient-derived tumor organoids-a therapeutic model in precision oncology

被引:0
|
作者
Schoemig, Linus R. [1 ]
Quante, Michael [1 ]
机构
[1] Univ Freiburg, Univ Klinikum Freiburg, Gastrointestinale Onkol, Klin Innere Med 2, Hugstetter Str 55, D-79106 Freiburg, Germany
来源
ONKOLOGIE | 2023年 / 29卷 / 01期
基金
美国国家卫生研究院;
关键词
Molecular tumor boards; Two-dimensional cell cultures; Xenografts; patient-derived; Functional analysis; Treatment model/oncology; STEM-CELLS; IN-VITRO; DISEASE; CULTURE; EXPANSION; PLATFORM; BIOBANK; MOUSE;
D O I
10.1007/s00761-022-01268-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Organoids are three-dimensional, multicellular and stem-cell-derived in vitro tissue cultures with self-organizing and self-renewing capabilities. In the field of personalized treatment approaches, organoids can serve as a suitable treatment model for molecular and functional analyses, due to their high similarities to the primary tissue that they were derived from. Especially in the field of precision oncology, where a high demand for patient-specific therapy models remains, organoids can serve as an alternative to conventional two-dimensional tissue culture and patient-derived xenografts.
引用
收藏
页码:74 / 84
页数:11
相关论文
共 50 条
  • [1] ASO Author Reflections: Patient-Derived Tumor Organoids-A Platform for a Precision Approach for Peritoneal Malignancies
    Forsythe, Steven D.
    Moaven, Omeed
    Votanopoulos, Konstantinos I.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 4961 - 4962
  • [2] Patient-Derived Cancer Organoids for Precision Oncology Treatment
    Pernik, Mark N.
    Bird, Cylaina E.
    Traylor, Jeffrey, I
    Shi, Diana D.
    Richardson, Timothy E.
    McBrayer, Samuel K.
    Abdullah, Kalil G.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [3] The promises and challenges of patient-derived tumor organoids in drug development and precision oncology
    Granat, Lauren M.
    Kambhampati, Ooha
    Klosek, Stephanie
    Niedzwecki, Brian
    Parsa, Kian
    Zhang, Dong
    [J]. ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2019, 2 (03) : 150 - 161
  • [4] The promises and challenges of patient-derived tumor organoids in drug development and precision oncology
    Lauren M.Granat
    Ooha Kambhampati
    Stephanie Klosek
    Brian Niedzwecki
    Kian Parsa
    Dong Zhang
    [J]. Animal Models and Experimental Medicine, 2019, 2 (03) : 150 - 161
  • [5] Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
    Thorel, Lucie
    Perreard, Marion
    Florent, Romane
    Divoux, Jordane
    Coffy, Sophia
    Vincent, Audrey
    Gaggioli, Cedric
    Guasch, Geraldine
    Gidrol, Xavier
    Weiswald, Louis-Bastien
    Poulain, Laurent
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (07): : 1531 - 1551
  • [6] Protocol for functional profiling of patient-derived organoids for precision oncology
    Nemati, Niloofar
    Boeck, Nina
    Lamberti, Giorgia
    Lisandrelli, Rebecca
    Trajanoski, Zlatko
    [J]. STAR PROTOCOLS, 2024, 5 (01):
  • [7] Patient derived organoids in precision oncology
    Valeri, Nicola
    [J]. CANCER RESEARCH, 2022, 82 (23) : 4 - 5
  • [8] Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
    Chitrangi, Swati
    Vaity, Pooja
    Jamdar, Aishwarya
    Bhatt, Shweta
    [J]. BMC CANCER, 2023, 23 (01)
  • [9] Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
    Swati Chitrangi
    Pooja Vaity
    Aishwarya Jamdar
    Shweta Bhatt
    [J]. BMC Cancer, 23
  • [10] New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
    Rago, Vittoria
    Perri, Anna
    Di Agostino, Silvia
    [J]. BIOMEDICINES, 2023, 11 (10)